IDEAS home Printed from https://ideas.repec.org/r/eee/respol/v20y1991i3p237-249.html
   My bibliography  Save this item

The governance of innovation: Vertical integration and collaborative arrangements in the biotechnology industry

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. David B. Audretsch & Dennis P. Leyden & Albert N. Link, 2013. "Universities as research partners in publicly supported entrepreneurial firms," Chapters, in: Public Support of Innovation in Entrepreneurial Firms, chapter 12, pages 175-192, Edward Elgar Publishing.
  2. Sobrero, Maurizio. & Roberts, Edward Baer., 1996. "The trade-off between efficiency and learning in inter-organizational relationships," Working papers 3896-96., Massachusetts Institute of Technology (MIT), Sloan School of Management.
  3. Darcy W E Allen, 2020. "When Entrepreneurs Meet:The Collective Governance of New Ideas," World Scientific Books, World Scientific Publishing Co. Pte. Ltd., number q0269, August.
  4. Mahka Moeen & Rajshree Agarwal & Sonali K. Shah, 2020. "Building Industries by Building Knowledge: Uncertainty Reduction over Industry Milestones," Strategy Science, INFORMS, vol. 5(3), pages 218-244, September.
  5. Ramani, Shyama V., 2002. "Who is interested in biotech? R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms," Research Policy, Elsevier, vol. 31(3), pages 381-398, March.
  6. Patrick Herbst & Uwe Walz, 2017. "The Design of Vertical R&D Collaborations," Economica, London School of Economics and Political Science, vol. 84(333), pages 54-77, January.
  7. Luigi Orsenigo & Fabio Pammolli & Massimo Riccaboni & Andrea Bonaccorsi & Giuseppe Turchetti, 1997. "The Evolution of Knowledge and the Dynamics of an Industry Network," Journal of Management & Governance, Springer;Accademia Italiana di Economia Aziendale (AIDEA), vol. 1(2), pages 147-175, June.
  8. Roijakkers, Nadine & Hagedoorn, John, 2006. "Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks," Research Policy, Elsevier, vol. 35(3), pages 431-446, April.
  9. Luukkonen, Terttu, 2003. "Variability in Forms of Organisation in Biotechnology Firms," Discussion Papers 872, The Research Institute of the Finnish Economy.
  10. Kalaitzandonakes, Nicholas G. & Hayenga, Marvin L., 2000. "Structural Change In The Biotechnology And Seed Industrial Complex: Theory And Evidence," Transitions in Agbiotech: Economics of Strategy and Policy, June 24-25, 1999, Washington, D.C. 26026, Regional Research Project NE-165 Private Strategies, Public Policies, and Food System Performance.
  11. Markus Solf, 2004. "Unternehmenskooperationen als Folge von Informations- und Kommunikations-technologieveränderungen: Eine theoretische Analyse," Schmalenbach Journal of Business Research, Springer, vol. 56(2), pages 146-167, March.
  12. Priyono Anjar & Dewi Elisabeth Ingga & Lim Sarina Abdul Halim, 2019. "Alliances as Dynamic Capability to Support Organizational Transformation: Empirical Findings from a State-Owned Enterprise," Foundations of Management, Sciendo, vol. 11(1), pages 93-102, January.
  13. Annika Rickne, 2006. "Connectivity and Performance of Science-based Firms," Small Business Economics, Springer, vol. 26(4), pages 393-407, May.
  14. Tahvanainen, Antti-Jussi, 2004. "Academic Spin-offs in Finnish Biotechnology," Discussion Papers 900, The Research Institute of the Finnish Economy.
  15. Francesco Calza & Adele Parmentola & Ilaria Tutore, 2021. "For green or not for green? The effect of cooperation goals and type on environmental performance," Business Strategy and the Environment, Wiley Blackwell, vol. 30(1), pages 267-281, January.
  16. Shweta Gaonkar & Mahka Moeen, 2023. "Standing on the parent's shoulder or in its shadow? Alliance partner overlap between employee spinouts and their parents," Strategic Management Journal, Wiley Blackwell, vol. 44(2), pages 415-440, February.
  17. Marcela Miozzo & Lori DiVito & Panos Desyllas, 2011. "Cross-border acquisitions of science-based firms: Their effect on innovation in the acquired firm and the local science," DRUID Working Papers 11-17, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
  18. Paola Giuri & John Hagedoorn & Myriam Mariani, 2002. "Technological Diversification and Strategic Alliances," LEM Papers Series 2002/04, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  19. Rothaermel, Frank T., 2001. "Complementary assets, strategic alliances, and the incumbent's advantage: an empirical study of industry and firm effects in the biopharmaceutical industry," Research Policy, Elsevier, vol. 30(8), pages 1235-1251, October.
  20. Signori, Andrea & Vismara, Silvio, 2018. "M&A synergies and trends in IPOs," Technological Forecasting and Social Change, Elsevier, vol. 127(C), pages 141-153.
  21. Li, Dan, 2013. "Multilateral R&D alliances by new ventures," Journal of Business Venturing, Elsevier, vol. 28(2), pages 241-260.
  22. Spedale-Latimer, S., 2002. "Inter-Firm Co-Operative Strategies In The Context Of Discontinuous Technological Change. The Case Of The Uk Optical Communications Systems Industry," ERIM Report Series Research in Management ERS-2002-112-STR, Erasmus Research Institute of Management (ERIM), ERIM is the joint research institute of the Rotterdam School of Management, Erasmus University and the Erasmus School of Economics (ESE) at Erasmus University Rotterdam.
  23. Potts, Jason & Kastelle, Tim, 2017. "Economics of innovation in Australian agricultural economics and policy," Economic Analysis and Policy, Elsevier, vol. 54(C), pages 96-104.
  24. Billette de Villemeur, Etienne & Versaevel, Bruno, 2019. "One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry," Journal of Health Economics, Elsevier, vol. 65(C), pages 260-283.
  25. Joshua S. Gans & David H. Hsu & Scott Stern, 2002. "When Does Start-Up Innovation Spur the Gale of Creative Destruction?," RAND Journal of Economics, The RAND Corporation, vol. 33(4), pages 571-586, Winter.
  26. K D S Fernald & H P G Pennings & J F van den Bosch & H R Commandeur & E Claassen, 2017. "The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-22, February.
  27. Bonnín Roca, Jaime & Vaishnav, Parth & Morgan, Granger M. & Fuchs, Erica & Mendonça, Joana, 2021. "Technology Forgiveness: Why emerging technologies differ in their resilience to institutional instability," Technological Forecasting and Social Change, Elsevier, vol. 166(C).
  28. Luc Armel G. Da Gbadji & Benoit Gailly & Armin Schwienbacher, 2015. "International Analysis of Venture Capital Programs of Large Corporations and Financial Institutions," Entrepreneurship Theory and Practice, , vol. 39(5), pages 1213-1246, September.
  29. Hong Luo, 2014. "When to Sell Your Idea: Theory and Evidence from the Movie Industry," Management Science, INFORMS, vol. 60(12), pages 3067-3086, December.
  30. Bruce Rasmussen, 2010. "Innovation and Commercialisation in the Biopharmaceutical Industry," Books, Edward Elgar Publishing, number 13680.
  31. Bodas Freitas, Isabel Maria & Gonçalves, Ricardo & Sousa, Rui, 2023. "Governance of new product design: The influence of national institutions," Journal of Business Research, Elsevier, vol. 165(C).
  32. Nicola Lacetera, 2001. "Corporate Governance and the Governance of Innovation: The Case of Pharmaceutical Industry," Journal of Management & Governance, Springer;Accademia Italiana di Economia Aziendale (AIDEA), vol. 5(1), pages 29-59, March.
  33. McCann, Brian T. & Folta, Timothy B., 2011. "Performance differentials within geographic clusters," Journal of Business Venturing, Elsevier, vol. 26(1), pages 104-123, January.
  34. Börjeson, Love, 2015. "Interorganizational situations – An explorative typology," European Management Journal, Elsevier, vol. 33(3), pages 191-200.
  35. Wang, Kai & Hong, Jin & Marinova, Dora & Zhu, Liang, 2009. "Evolution and governance of the biotechnology and pharmaceutical industry of China," Mathematics and Computers in Simulation (MATCOM), Elsevier, vol. 79(9), pages 2947-2956.
  36. Sharmistha Bagchi-Sen & Helen Lawton Smith, 2014. "Firm Heterogeneity in Biotech: Absorptive Capacity, Strategies and Local-Regional Connections," European Planning Studies, Taylor & Francis Journals, vol. 22(9), pages 1783-1801, September.
  37. Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2005. "The knowledge bases of the world's largest pharmaceutical groups: what do patent citations to non-patent literature reveal?," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 14(5), pages 395-415.
  38. Birch, Kean & Ward, Callum & Tretter, Eliot, 2022. "Introduction: new frontiers of techno-economic rentiership," LSE Research Online Documents on Economics 115135, London School of Economics and Political Science, LSE Library.
  39. Elizabeth Webster & Paul H. Jensen, 2011. "Do Patents Matter for Commercialization?," Journal of Law and Economics, University of Chicago Press, vol. 54(2), pages 431-453.
  40. Devarakonda, Ramakrishna & Reuer, Jeffrey J. & Tadikonda, Harsha, 2022. "Founder social capital and value appropriation in R&D alliance agreements," Research Policy, Elsevier, vol. 51(4).
  41. Fengchao Liu & Na Zhang & Cong Cao, 2017. "An evolutionary process of global nanotechnology collaboration: a social network analysis of patents at USPTO," Scientometrics, Springer;Akadémiai Kiadó, vol. 111(3), pages 1449-1465, June.
  42. Scott Shane, 2002. "Selling University Technology: Patterns from MIT," Management Science, INFORMS, vol. 48(1), pages 122-137, January.
  43. Najib Harabi, 2002. "The Impact of Vertical R&D Cooperation on Firm Innovation: An Empirical Investigation," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 11(2), pages 93-108.
  44. Hoenig, Daniel & Henkel, Joachim, 2015. "Quality signals? The role of patents, alliances, and team experience in venture capital financing," Research Policy, Elsevier, vol. 44(5), pages 1049-1064.
  45. Gary P. Pisano, 2017. "Toward a prescriptive theory of dynamic capabilities: connecting strategic choice, learning, and competition," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 26(5), pages 747-762.
  46. Darcy W.E. Allen, 2019. "Governing the entrepreneurial discovery of blockchain applications," Journal of Entrepreneurship and Public Policy, Emerald Group Publishing Limited, vol. 9(2), pages 194-212, October.
  47. Tapon, Francis & Cadsby, Charles Bram, 1996. "The optimal organization of research: evidence from eight case studies of pharmaceutical firms," Journal of Economic Behavior & Organization, Elsevier, vol. 31(3), pages 381-399, December.
  48. Luukkonen, Terttu, 2002. "Technology and market orientation in company participation in the EU framework programme," Research Policy, Elsevier, vol. 31(3), pages 437-455, March.
  49. Dushnitsky, Gary & Lenox, Michael J., 2005. "When do incumbents learn from entrepreneurial ventures?: Corporate venture capital and investing firm innovation rates," Research Policy, Elsevier, vol. 34(5), pages 615-639, June.
  50. Colombo, Massimo G. & D’Adda, Diego & Pirelli, Lorenzo H., 2016. "The participation of new technology-based firms in EU-funded R&D partnerships: The role of venture capital," Research Policy, Elsevier, vol. 45(2), pages 361-375.
  51. Shawn Bolouki & Peter Lewa, 2018. "An Exploratory Study of the Impact of Top Leadership on Effectiveness of Privatization of Hospitals Through Mergers and Acquisitions in Kenya," Journal of Management and Strategy, Journal of Management and Strategy, Sciedu Press, vol. 9(3), pages 54-87, August.
  52. Luukkonen, Terttu, 2005. "Variability in organisational forms of biotechnology firms," Research Policy, Elsevier, vol. 34(4), pages 555-570, May.
  53. Orsenigo, L. & Pammolli, F. & Riccaboni, Massimo, 2001. "Technological change and network dynamics: Lessons from the pharmaceutical industry," Research Policy, Elsevier, vol. 30(3), pages 485-508, March.
  54. Luo, Xiaowei Rose & Koput, Kenneth W. & Powell, Walter W., 2009. "Intellectual capital or signal? The effects of scientists on alliance formation in knowledge-intensive industries," Research Policy, Elsevier, vol. 38(8), pages 1313-1325, October.
  55. Häussler, Carolin, 2006. "Can’t Buy Me Rights! The Contractual Structure of Asymmetrical Inter-firm Collaborations," Discussion Paper Series of SFB/TR 15 Governance and the Efficiency of Economic Systems 189, Free University of Berlin, Humboldt University of Berlin, University of Bonn, University of Mannheim, University of Munich.
  56. Czarnitzki, Dirk & Hottenrott, Hanna, 2012. "Collaborative R&D as a strategy to attenuate financing constraints," ZEW Discussion Papers 12-049, ZEW - Leibniz Centre for European Economic Research.
  57. Klaus Kultti & Tuomas Takalo & Tanja Tanayama, 2015. "R&D spillovers and information exchange: a case study," Eurasian Economic Review, Springer;Eurasia Business and Economics Society, vol. 5(1), pages 63-76, June.
  58. Fabio Pammolli & Massimo Riccaboni & Alessandro Spelta, 2021. "The network origins of Schumpeterian innovation," Journal of Evolutionary Economics, Springer, vol. 31(5), pages 1411-1431, November.
  59. Garud, Raghu & Gehman, Joel & Giuliani, Antonio Paco, 2014. "Contextualizing entrepreneurial innovation: A narrative perspective," Research Policy, Elsevier, vol. 43(7), pages 1177-1188.
  60. Benjamin Clark, 2011. "Influences and conflicts of federal policies in academic–industrial scientific collaboration," The Journal of Technology Transfer, Springer, vol. 36(5), pages 514-545, October.
  61. BELDERBOS, René & GILSING, Victor & SUZUKI, Shinya, 2015. "Direct And Mediated Ties To Universities: ‘Scientific’ Absorptive Capacity And Innovation Performance Of Pharmaceutical Firms," Discussion paper series 2015-06, Hitotsubashi Institute for Advanced Study, Hitotsubashi University.
  62. Sharmistha Bagchi-Sen, 2006. "Strategic Considerations for Innovation and Commercialization in the US Biotechnology Sector," European Planning Studies, Taylor & Francis Journals, vol. 15(6), pages 753-766, May.
  63. Annika Lorenz & Michael Raven & Knut Blind, 2019. "The role of standardization at the interface of product and process development in biotechnology," The Journal of Technology Transfer, Springer, vol. 44(4), pages 1097-1133, August.
  64. Avenel, E. & Corolleur, F. & Gauthier, C. & Rieu, C., 2005. "Start-ups, firm growth and the consolidation of the French biotech industry," Working Papers 200503, Grenoble Applied Economics Laboratory (GAEL).
  65. Meuer, Johannes & Rupietta, Christian & Backes-Gellner, Uschi, 2015. "Layers of co-existing innovation systems," Research Policy, Elsevier, vol. 44(4), pages 888-910.
  66. Colombo, Massimo G. & Grilli, Luca & Piva, Evila, 2006. "In search of complementary assets: The determinants of alliance formation of high-tech start-ups," Research Policy, Elsevier, vol. 35(8), pages 1166-1199, October.
  67. Billette de Villemeur, Etienne & Scannell, Jack & Versaevel, Bruno, 2021. "Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?," MPRA Paper 108233, University Library of Munich, Germany.
  68. Tripsas, Mary & Schrader, Stephan & Sobrero, Maurizio, 1995. "Discouraging opportunistic behavior in collaborative R & D: A new role for government," Research Policy, Elsevier, vol. 24(3), pages 367-389, May.
  69. Bonnín Roca, Jaime & Vaishnav, Parth & Morgan, M.Granger & Mendonça, Joana & Fuchs, Erica, 2017. "When risks cannot be seen: Regulating uncertainty in emerging technologies," Research Policy, Elsevier, vol. 46(7), pages 1215-1233.
  70. Versaevel, Bruno & de Villemeur, Étienne, 2003. "Conflict and Cooperation on R&D Markets," IDEI Working Papers 191, Institut d'Économie Industrielle (IDEI), Toulouse.
  71. Hagedoorn, John, 2000. "External Appropriation of Innovative Capabilities: The Preference for Strategic Alliances or M&AS," Research Memorandum 008, Maastricht University, Maastricht Economic Research Institute on Innovation and Technology (MERIT).
  72. M. C. Guardo & K. R. Harrigan, 2016. "Shaping the path to inventive activity: the role of past experience in R&D alliances," The Journal of Technology Transfer, Springer, vol. 41(2), pages 250-269, April.
  73. Mostak Ahamed Galib & Kamrun Nahar Munny, 2015. "The Inclusion of Academicians into the Industry Sector in Bangladesh: A Model of Industry Engagement and Effective Innovation Performance," International Journal of Management Science and Business Administration, Inovatus Services Ltd., vol. 1(6), pages 7-18, May.
  74. Massimo G. Colombo & Evila Piva & Francesco Rentocchini, 2012. "The effects of incubation on academic and non-academic high-tech start-ups: evidence from Italy," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 21(5-6), pages 505-527, December.
  75. Monica C. Higgins & Ranjay Gulati, 2003. "Getting Off to a Good Start: The Effects of Upper Echelon Affiliations on Underwriter Prestige," Organization Science, INFORMS, vol. 14(3), pages 244-263, June.
  76. Numagami, Tsuyoshi, 1996. "Flexibility trap: a case analysis of U.S. and Japanese technological choice in the digital watch industry," Research Policy, Elsevier, vol. 25(1), pages 133-162, January.
  77. Yoo, Dasun & Reimann, Felix, 2017. "Internationalization of Developing Country Firms into Developed Countries: The Role of Host Country Knowledge-Based Assets and IPR Protection in FDI Location Choice," Journal of International Management, Elsevier, vol. 23(3), pages 242-254.
  78. Boardman, P. Craig & Corley, Elizabeth A., 2008. "University research centers and the composition of research collaborations," Research Policy, Elsevier, vol. 37(5), pages 900-913, June.
  79. Luigi Orsenigo & Fabio Pammolli & Massimo Riccaboni, 1999. "Competencies, Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry," LEM Papers Series 1999/13, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  80. Bercovitz, Janet E.L. & Feldman, Maryann P., 2007. "Fishing upstream: Firm innovation strategy and university research alliances," Research Policy, Elsevier, vol. 36(7), pages 930-948, September.
  81. Margarida Fontes, 2005. "Distant networking: The knowledge acquisition strategies of 'out-cluster' biotechnology firms," European Planning Studies, Taylor & Francis Journals, vol. 13(6), pages 899-920, September.
  82. Roucan-Kane, Maud & Pena, Inaki & Boehlje, Michael & Akridge, Jay T., 2009. "Factors Influencing Organizational Structure In The Food Manufacturing, Chemical, Agricultural Wholesaling And Biotechnology Industries," Working papers 47454, Purdue University, Department of Agricultural Economics.
  83. Jaideep Anand & Raffaele Oriani & Roberto S. Vassolo, 2010. "Alliance Activity as a Dynamic Capability in the Face of a Discontinuous Technological Change," Organization Science, INFORMS, vol. 21(6), pages 1213-1232, December.
  84. Franco Malerba & Luigi Orsenigo, 2000. "Towards a History Friendly Model of Innovation, Market Structure and Regulation in the Dynamics of the Pharmaceutical Industry: the Age of Random Screening," KITeS Working Papers 124, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy, revised Jan 2001.
  85. Greis, Noel P. & Dibner, Mark D. & Bean, Alden S., 1995. "External partnering as a response to innovation barriers and global competition in biotechnology," Research Policy, Elsevier, vol. 24(4), pages 609-630, July.
  86. Ajay Agrawal & Iain Cockburn & Laurina Zhang, 2015. "Deals not done: Sources of failure in the market for ideas," Strategic Management Journal, Wiley Blackwell, vol. 36(7), pages 976-986, July.
  87. Sobrero, Maurizio & Roberts, Edward B., 2002. "Strategic management of supplier-manufacturer relations in new product development," Research Policy, Elsevier, vol. 31(1), pages 159-182, January.
  88. Higgins, Matthew J. & Rodriguez, Daniel, 2006. "The outsourcing of R&D through acquisitions in the pharmaceutical industry," Journal of Financial Economics, Elsevier, vol. 80(2), pages 351-383, May.
  89. Kerstin Press, 2006. "Divide to conquer? The Silicon Valley - Boston 128 case revisited," Papers in Evolutionary Economic Geography (PEEG) 0610, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Dec 2006.
  90. Cantner, Uwe & Rake, Bastian, 2014. "International research networks in pharmaceuticals: Structure and dynamics," Research Policy, Elsevier, vol. 43(2), pages 333-348.
  91. Harabi, Najib, 1997. "Vertical Relations Between Firms and Innovation: An Empirical Investigation of German Firms," ZEW Discussion Papers 97-10, ZEW - Leibniz Centre for European Economic Research.
  92. Kamrun Nahar Munny & Mostak Ahamed Galib & Ding Lin, 2015. "Scientists Collaborating with Industry: An Exploration of Industry Engagement Types," International Journal of Management Science and Business Administration, Inovatus Services Ltd., vol. 1(8), pages 37-46, July.
  93. Gans, Joshua S. & Stern, Scott, 2003. "The product market and the market for "ideas": commercialization strategies for technology entrepreneurs," Research Policy, Elsevier, vol. 32(2), pages 333-350, February.
  94. Kim, Jerry W. & Higgins, Monica C., 2007. "Where do alliances come from?: The effects of upper echelons on alliance formation," Research Policy, Elsevier, vol. 36(4), pages 499-514, May.
  95. Hermano, Víctor & Martín-Cruz, Natalia, 2013. "How to Deliver Foreign Aid? The Case of Projects Governed by the Spanish International Agency," World Development, Elsevier, vol. 43(C), pages 298-314.
  96. Heydebrand, Wolf, 2009. "Accounting for great expectations: Lessons from the new media surge for critical management theory," CRITICAL PERSPECTIVES ON ACCOUNTING, Elsevier, vol. 20(3), pages 418-444.
  97. Wang, Chun-Hsien & Chang, Ching-Hsing & Shen, George C., 2015. "The effect of inbound open innovation on firm performance: Evidence from high-tech industry," Technological Forecasting and Social Change, Elsevier, vol. 99(C), pages 222-230.
  98. Xia Wang, 2005. "Technological Characteristics and R&D Alliance Form: Evidence from the U.S. Biotechnology Industry," Working papers 2005-35, University of Connecticut, Department of Economics.
  99. Kollmer, Holger & Dowling, Michael, 2004. "Licensing as a commercialisation strategy for new technology-based firms," Research Policy, Elsevier, vol. 33(8), pages 1141-1151, October.
  100. Moreira, Solon & Klueter, Thomas Maximilian & Asija, Aman, 2023. "Market for technology 2.0? Reassessing the role of complementary assets on licensing decisions," Research Policy, Elsevier, vol. 52(7).
  101. Charlotte C. Rank & Olaf N. Rank & Andreas Wald, 2005. "Netzwerke in der Biotechnologie," Schmalenbach Journal of Business Research, Springer, vol. 57(7), pages 617-634, November.
  102. Link, Al & Wessner, Charles, 2010. "Universities as Research Partners: Entrepreneurial Explorations and Exploitations," UNCG Economics Working Papers 10-12, University of North Carolina at Greensboro, Department of Economics.
  103. Roijakkers, Nadine & Hagedoorn, John & van Kranenburg, Hans, 2005. "Dual market structures and the likelihood of repeated ties - evidence from pharmaceutical biotechnology," Research Policy, Elsevier, vol. 34(2), pages 235-245, March.
  104. Bozeman, Barry & Corley, Elizabeth, 2004. "Scientists' collaboration strategies: implications for scientific and technical human capital," Research Policy, Elsevier, vol. 33(4), pages 599-616, May.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.